SIA
ELV icon

Stancorp Investment Advisers’s Elevance Health ELV Stock Holding History

Stancorp Investment Advisers’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$10K Hold
65
– – ﹤0.01% 452
2014
Q4 		$8K Buy
+65
New +$8.03K ﹤0.01% 452

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Stancorp Investment Advisers's ELV Position: Q1 2015 in Review

Stancorp Investment Advisers held its Elevance Health (ELV) position steady in Q1 2015 at 65 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #452.

Stancorp Investment Advisers first reported a position in ELV in Q4 2014 and has held it in 2 quarters since. 752 funds tracked by Wall St. Rank hold ELV as of Q1 2015.

  • Stancorp Investment Advisers held 65 shares of Elevance Health worth $10K as of Q1 2015.
  • Stancorp Investment Advisers left its Elevance Health share count unchanged in Q1 2015.
  • Elevance Health made up ﹤0.01% of Stancorp Investment Advisers's portfolio in Q1 2015, its #452 holding.
  • Stancorp Investment Advisers first reported a position in Elevance Health in Q4 2014 and has held it in 2 quarters since.
  • 752 funds tracked by Wall St. Rank held Elevance Health as of Q1 2015.

Based on Stancorp Investment Advisers's 13F filing for Q1 2015, filed 13 May 2015.